HLA Molecular Products

Olerup XM-ONE®

CareDx logo

XM-ONE® provides additional information compared to the currently used lymphocyte crossmatch tests and therefore improves the basis for risk assessment prior to transplantation.

XM-ONE® Proficiency Testing Program

Accuracy and standardization of crossmatch results between different centers are essential in organ transplantation. The XM-ONE® proficiency testing (PT) program serves as an important function in accomplishing this goal. The PT program for XM-ONE® is approved by The American Society for Histocompatibility and Immunogenetics (ASHI).

XM-ONE® Multicenter Study

The study showed that the XM-ONE® test can detect an antibody population not possible to detect with lymphocyte crossmatch tests that is strongly associated with rejection episodes and reduced kidney function after transplantation. Thus the XM-ONE® test can identify patients at risk of antibody-mediated rejections.

Scroll to Top